Literature DB >> 4015230

Lung vascular injury with protease infusion. Relationship to plasma fibronectin.

L F Cohler, T M Saba, E P Lewis.   

Abstract

Fibronectin exists in a soluble form in plasma and in an insoluble form in tissues. Plasma fibronectin can modulate phagocytic function as well as incorporate into the tissue matrix where it is believed to influence microvascular integrity and tissue repair. The temporal alterations in plasma and lung lymph fibronectin were studied in relation to increased pulmonary vascular permeability induced by protease infusion. The acute sheep lung lymph fistula model was used. A 39% decrease in plasma fibronectin (control = 421 +/- 67 micrograms/ml) was observed 2.5 hours (255 +/- 43 micrograms/ml) after protease infusion. There was an elevation of lymph fibronectin early after protease infusion, followed by a progressive decline. Concomitant with the decrease in plasma fibronectin, an increase in lymph flow (QL) of greater than 200% (from a control of 6.7 +/- 1.0 ml/hr to 13.9 +/- 1.4 ml/hr) was observed within 2.5 hours. Also, there was a sustained elevation in the total protein lymph/plasma concentration (L/P) ratio, which was maximal at 2.5 hours. The transvascular protein clearance (TVPC = QL X L/P) was 4.5 +/- 0.7 ml/hr at the control period and 13.1 +/- 2.0 ml/hr by 2.5 hours. This was indicative of increased flux of protein-rich fluid across the pulmonary endothelial barrier. Lung vascular permeability stabilized after 2.5 hours as manifested by a slowly declining L/P ratio. Thus, plasma fibronectin deficiency may contribute to the etiology of increased lung vascular permeability with protease infusion. Since the progressive decline in plasma fibronectin was not reflected in a proportional increase in lymph fibronectin, plasma fibronectin may have sequestered in tissues such as the lung, or perhaps in reticuloendothelial cells during the injury phase. Whether the progressive decrease in plasma fibronectin reflects its incorporation into the endothelial barrier matrix where it may mediate stabilization of the pulmonary microvascular barrier remains to be determined.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4015230      PMCID: PMC1250880          DOI: 10.1097/00000658-198508000-00016

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  38 in total

1.  Comparative disappearance and localization of isotopically labeled opsonic protein and soluble albumin following surgical trauma.

Authors:  J E Kaplan; J Molnar; T M Saba; C Allen
Journal:  J Reticuloendothel Soc       Date:  1976-11

2.  Preparation of chronic lung lymph fistulas in sheep.

Authors:  N C Staub; R D Bland; K L Brigham; R Demling; A J Erdmann; W C Woolverton
Journal:  J Surg Res       Date:  1975-11       Impact factor: 2.192

3.  Binding of soluble form of fibroblast surface protein, fibronectin, to collagen.

Authors:  E Engvall; E Ruoslahti
Journal:  Int J Cancer       Date:  1977-07-15       Impact factor: 7.396

4.  Respiratory complications in acute pancreatitis.

Authors:  J H Ranson; J W Turner; D F Roses; K M Rifkind; F C Spencer
Journal:  Ann Surg       Date:  1974-05       Impact factor: 12.969

5.  Reticuloendothelial blockade and recovery as a function of opsonic activity.

Authors:  T M Saba; N R Di Luzio
Journal:  Am J Physiol       Date:  1969-01

6.  Biochemical and immunological characterization of human opsonic alpha2SB glycoprotein: its identity with cold-insoluble globulin.

Authors:  F A Blumenstock; T M Saba; P Weber; R Laffin
Journal:  J Biol Chem       Date:  1978-06-25       Impact factor: 5.157

7.  A study of pancreatic enzymes as a factor in the pathogenesis of disseminated intravascular coagulation during acute pancreatitis.

Authors:  H C Kwaan; M C Anderson; L Gramatica
Journal:  Surgery       Date:  1971-05       Impact factor: 3.982

8.  Increased sheep lung vascular permeability caused by pseudomonas bacteremia.

Authors:  K L Brigham; W C Woolverton; L H Blake; N C Staub
Journal:  J Clin Invest       Date:  1974-10       Impact factor: 14.808

9.  Hemodialysis leukopenia. Pulmonary vascular leukostasis resulting from complement activation by dialyzer cellophane membranes.

Authors:  P R Craddock; J Fehr; A P Dalmasso; K L Brighan; H S Jacob
Journal:  J Clin Invest       Date:  1977-05       Impact factor: 14.808

10.  Distribution of a major connective tissue protein, fibronectin, in normal human tissues.

Authors:  S Stenman; A Vaheri
Journal:  J Exp Med       Date:  1978-04-01       Impact factor: 14.307

View more
  2 in total

Review 1.  Fibronectin and the critically ill patient: current status.

Authors:  T M Saba; J L Kiener; J M Holman
Journal:  Intensive Care Med       Date:  1986       Impact factor: 17.440

2.  Role of fibronectin in pancreatitis-associated lung injury.

Authors:  Charles F Bellows; Joseph D Brain
Journal:  Dig Dis Sci       Date:  2003-08       Impact factor: 3.199

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.